NCT04171167View on ClinicalTrials.gov

The Causal Relation of Nasal Nitric Oxide Levels to the Severity of Chronic Rhinosinusitis and Its Inflammatory Phenotype

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Chronic Rhinosinusitis (Diagnosis)

Interventions

DRUG

Fluticasone Propionate

three visits: 0, after washout, after FP usage

Trial Locations (1)

Unknown

Tampere University Hospital, Tampere

All Listed Sponsors

lead

Tampere University Hospital

OTHER

NCT04171167 - The Causal Relation of Nasal Nitric Oxide Levels to the Severity of Chronic Rhinosinusitis and Its Inflammatory Phenotype | Biotech Hunter | Biotech Hunter